Dendritic cells (DCs) are critical for antigen presentation and immune responses. This study investigates the presence and proliferation of DC progenitors in human blood, focusing on their potential for clinical applications. CD34⁺ cells in cord blood and marrow are known to give rise to DCs and other myeloid lineages, but they are rare in adult blood. The study aimed to determine if DC progenitors exist in the circulation and if blood can be a source for large numbers of immunostimulatory DCs. In cord blood, depleting erythroid progenitors and adding GM-CSF and TNF led to the formation of DC aggregates. In adult blood from cancer patients, GM-CSF and TNF also generated DCs from HLA-DR negative precursors. However, in healthy adults, these approaches only produced small DC aggregates that seemed to become monocytes. Adding IL-4 suppressed monocyte development and led to the formation of large proliferating DC aggregates, with many nonproliferating progeny. These DCs had a characteristic morphology and surface composition, and were potent stimulators of quiescent T cells. The study found that large numbers of DCs can be mobilized from progenitors in the bloodstream using specific cytokines. These DCs can be used to study their FcεRI and CD4 receptors, and their role in stimulating T cell-mediated resistance to viruses and tumors. The study also identified that DC progenitors are present in human blood, and that the criteria for identifying them in mouse blood are applicable to humans. The study demonstrated that DC progenitors can be cultured from cord blood and blood of cancer patients, and that IL-4 and GM-CSF are essential for their growth and maturation. The study highlights the potential of DCs in clinical applications, such as antigen presentation and immune responses.Dendritic cells (DCs) are critical for antigen presentation and immune responses. This study investigates the presence and proliferation of DC progenitors in human blood, focusing on their potential for clinical applications. CD34⁺ cells in cord blood and marrow are known to give rise to DCs and other myeloid lineages, but they are rare in adult blood. The study aimed to determine if DC progenitors exist in the circulation and if blood can be a source for large numbers of immunostimulatory DCs. In cord blood, depleting erythroid progenitors and adding GM-CSF and TNF led to the formation of DC aggregates. In adult blood from cancer patients, GM-CSF and TNF also generated DCs from HLA-DR negative precursors. However, in healthy adults, these approaches only produced small DC aggregates that seemed to become monocytes. Adding IL-4 suppressed monocyte development and led to the formation of large proliferating DC aggregates, with many nonproliferating progeny. These DCs had a characteristic morphology and surface composition, and were potent stimulators of quiescent T cells. The study found that large numbers of DCs can be mobilized from progenitors in the bloodstream using specific cytokines. These DCs can be used to study their FcεRI and CD4 receptors, and their role in stimulating T cell-mediated resistance to viruses and tumors. The study also identified that DC progenitors are present in human blood, and that the criteria for identifying them in mouse blood are applicable to humans. The study demonstrated that DC progenitors can be cultured from cord blood and blood of cancer patients, and that IL-4 and GM-CSF are essential for their growth and maturation. The study highlights the potential of DCs in clinical applications, such as antigen presentation and immune responses.